SCHEMBL486047

SCHEMBL486047

COC(=O)C(O)(c1c(C)[nH]n(-c2ccc(-c3ccccc3)cc2)c1=O)C(F)(F)F

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.87
MAPT P10636 4/20 0.87
LMNA P02545 3/20 0.87
ALOX15 P16050 2/20 0.87
ALDH1A1 P00352 2/20 0.87
APAF1 O14727 1/20 0.87
TDP2 O95551 1/20 0.87
THRB P10828 1/20 0.87
TDP1 Q9NUW8 1/20 0.87
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2C19 P33261 3/20 0.49
CYP2C9 P11712 1/20 0.49
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486090 0.93 GAA (1.00) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486328 0.89 MAPT (0.83) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486323 0.89 GAA (0.82) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486229 0.88 GAA (0.82) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486407 0.87 MAPT (0.80) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486248 0.86 GAA (0.79) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486288 0.86 GAA (0.79) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486142 0.86 GAA (0.79) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486271 0.85 GAA (0.77) GAAMAPTLMNAALOX15ALDH1A1
SCHEMBL486178 0.84 ALDH1A1 (0.76) GAAMAPTLMNAALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2145884-B1 INDOLEDIONE DERIVATIVE MSD KK (JP) 2014-08-06 EP disclosed
US-8106086-B2 Indoledione derivative MSD K.K. (JP) 2012-01-31 US disclosed
US-20100056597-A1 INDOLEDIONE DERIVATIVE MSD K.K. (JP) 2010-03-04 US disclosed
EP-2145884-A1 INDOLEDIONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056597-A1 INDOLEDIONE DERIVATIVE LIPE, IDO1, ADRA1A GAA 3701/4885MAPT 2831/4885LMNA 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.